- Telehealth visits
- Insurance plan information
Nicholas A. Butowski, MD
Neuro-Oncology- Telehealth visits
- Insurance plan information
Nicholas A. Butowski, MD
Neuro-Oncology- Telehealth visits
- Insurance plan information
On this page
About me
Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders. He is director of clinical services in neuro-oncology and a researcher at the Brain Tumor Center.
In his research, Butowski focuses on developing treatments for primary brain tumors as well as methods to ensure good quality of life for patients and to assist them in recovering from or coping with brain injury.
Butowski earned his medical degree at the University of Illinois at Chicago. He completed a residency in neurology and a fellowship in neuro-oncology at UCSF. He is a member of the American Academy of Neurology, American Society of Clinical Oncology and Society for Neuro-oncology.
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neuro-Oncology, UCSF Medical Center - OMAG
Residency
- Neurology, UCSF Medical Center - OMAG
Internship
- Internal Medicine, Evanston Northwestern Healthcare Internal Med Res
Degree
- MD, University of Illinois School of Medicine-Chicago
Academic title
- Clinical Professor
My expertise
Specialties
Conditions
Locations
My research
Clinical trials
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaOpens in a new window
Recruiting
Overall survival is defined from the time of randomization to death from any cause. Patients still alive at the time of an analysis will be considered censored...A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care TreatmentOpens in a new window
Recruiting
Will be calculated as the number of days from the date of patient registration to the date of death.DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaOpens in a new window
Recruiting
Tolerability is defined as the proportion of participants receiving at least one dose of DB107-RRV and DB107-FC with a reported dose-limiting toxicity for all...
Publications
Showing 1-6 of 71 reviews
- August 27, 20265 out of 5 Stars
Very professional, got right down to business.
- August 19, 20265 out of 5 Stars
The entire neuro oncology team is exceptional. I am so grateful . For the care I am receiving. Thank you,!!
- August 5, 20265 out of 5 Stars
Very patient oriented Dr.
- July 31, 20265 out of 5 Stars
Exemplary provider. I am grateful to be under his care.
- July 30, 20265 out of 5 Stars
Dr Butowski's care and knowledge are unparalleled.
- July 22, 20265 out of 5 Stars
Dr. Butowski is a world class physician who loves his job and helping patients. I feel he truely cares about his patients and is invested in their health.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.